Intravenous (IV) Solution Market by Types, Nutritional Content, and End Users - Global Industry Analysis & Forecast to 2027
Published On : September 2019 Pages : 154 Category: Pharmaceuticals Report Code : HC095745
Intravenous (IV) Solution Market by Types (Peripheral Parenteral Nutrition, Total Parenteral Nutrition) Nutritional Content (Carbohydrates, Parenteral Lipid Emulsion, Carbohydrates, Amino Acid Solution, Other) End Users (Hospital & Clinics, Home Care, Ambulatory) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The intravenous (IV) solution market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Intravenous (IV) is a method for administering concentrated prescriptions (diluted or undiluted) straightforwardly into the vein utilizing a syringe through a needleless port on a current IV line or a saline lock. The direct IV route as a rule oversees a little volume of liquid/drug (max 20 ml) that is pushed manually into the patient. Drugs given by IV are typically regulated irregularly to treat developing concerns. Intravenous medications can convey an immediate, fast-acting therapeutic effect, which is significant in emanant circumstances, such as cardiac arrest or narcotic overdose.
Drivers and Restraints
Rise in prevalence of chronic diseases drives the growth of intravenous (IV) solution market. According to world health organization, by 2021, chronic diseases is expected to rise to 73% of all deaths and 60% of the global burden of disease. Government initiatives and support propels the growth of intravenous (IV) solution market. IV nourishment forms an integral piece of any treatment to satisfy wholesome necessities and help in quicker recovery in patients that in turn fuels the growth of intravenous (IV) solution market. Continuous demand for IV solutions provides beneficial opportunities for the intravenous (IV) solution market.
Regional Insights
Among the geographies, North America is expected to dominate the intravenous (IV) solution market. Rising expenditure on healthcare in the region contribute to the growth of intravenous (IV) solution market.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Baxter (US)
- Amanta Healthcare (India).
- Fresenius Kabi AG (Germany)
- Terumo Corporation (Japan)
- B. Braun Melsungen AG (Germany)
- Grifols, SA (Spain)
- ICU Medical, Inc. (US)
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Intravenous (IV) Solution Market, By Types, Estimates and Forecast, 2017-2027 ($Million)
o Peripheral Parenteral Nutrition
o Total Parenteral Nutrition
· Intravenous (IV) Solution Market, By Nutritional Content, Estimates and Forecast, 2017-2027 ($Million)
o Carbohydrates
o Parenteral Lipid Emulsion
o Carbohydrates
o Amino Acid Solution
o Other
· Intravenous (IV) Solution Market, By End Users, Estimates and Forecast, 2017-2027 ($Million)
o Hospital & Clinics
o Home Care
o Ambulatory
· Intravenous (IV) Solution Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Baxter (US)
o Amanta Healthcare (India).
o Fresenius Kabi AG (Germany)
o Terumo Corporation (Japan)
o B. Braun Melsungen AG (Germany)
o Grifols, SA (Spain)
o ICU Medical, Inc. (US)
· Intravenous (IV) Solution Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Intravenous (IV) Solution Market, By Country
o U.S. Intravenous (IV) Solution Market
o Canada Intravenous (IV) Solution Market
o Mexico Intravenous (IV) Solution Market
o Europe
§ Europe Intravenous (IV) Solution Market, By Country
· Germany Intravenous (IV) Solution Market
o UK Intravenous (IV) Solution Market
o France Intravenous (IV) Solution Market
o Russia Intravenous (IV) Solution Market
o Italy Intravenous (IV) Solution Market
o Rest of Europe Intravenous (IV) Solution Market
o Asia-Pacific
§ Asia-Pacific Intravenous (IV) Solution Market, By Country
o China Intravenous (IV) Solution Market
o Japan Intravenous (IV) Solution Market
o South Korea Intravenous (IV) Solution Market
o India Intravenous (IV) Solution Market
o Southeast Asia Intravenous (IV) Solution Market
o Rest of Asia-Pacific Intravenous (IV) Solution Market
o South America
§ South America Intravenous (IV) Solution Market
o Brazil Intravenous (IV) Solution Market
o Argentina Intravenous (IV) Solution Market
o Columbia Intravenous (IV) Solution Market
o Rest of South America Intravenous (IV) Solution Market
o Middle East and Africa
§ Middle East and Africa Intravenous (IV) Solution Market
o Saudi Arabia Intravenous (IV) Solution Market
o UAE Intravenous (IV) Solution Market
o Egypt Intravenous (IV) Solution Market
o Nigeria Intravenous (IV) Solution Market
o South Africa Intravenous (IV) Solution Market
o Rest of MEA Intravenous (IV) Solution Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Intravenous (IV) Solution Market, By Types
5.1. Introduction
5.2. Global Intravenous (IV) Solution Revenue and Market Share by Types (2017-2027)
5.2.1. Global Intravenous (IV) Solution Revenue and Revenue Share by Types (2017-2027)
5.3. Peripheral Parenteral Nutrition
5.3.1. Global Peripheral Parenteral Nutrition Revenue and Growth Rate (2017-2027)
5.4. Total Parenteral Nutrition
5.4.1. Global Total Parenteral Nutrition Revenue and Growth Rate (2017-2027)
6. Intravenous (IV) Solution Market, By Nutritional Content
6.1. Introduction
6.2. Global Intravenous (IV) Solution Revenue and Market Share by Nutritional Content (2017-2027)
6.2.1. Global Intravenous (IV) Solution Revenue and Revenue Share by Nutritional Content (2017-2027)
6.3. Carbohydrates
6.3.1. Global Carbohydrates Revenue and Growth Rate (2017-2027)
6.4. Parenteral Lipid Emulsion
6.4.1. Global Parenteral Lipid Emulsion Revenue and Growth Rate (2017-2027)
6.5. Carbohydrates
6.5.1. Global Carbohydrates Revenue and Growth Rate (2017-2027)
6.6. Amino Acid Solution
6.6.1. Global Amino Acid Solution Revenue and Growth Rate (2017-2027)
6.7. Other
6.7.1. Global Other Revenue and Growth Rate (2017-2027)
7. Intravenous (IV) Solution Market, By End Users
7.1. Introduction
7.2. Global Intravenous (IV) Solution Revenue and Market Share by End Users (2017-2027)
7.2.1. Global Intravenous (IV) Solution Revenue and Revenue Share by End Users (2017-2027)
7.3. Hospital & Clinics
7.3.1. Global Hospital & Clinics Revenue and Growth Rate (2017-2027)
7.4. Home Care
7.4.1. Global Home Care Revenue and Growth Rate (2017-2027)
7.5. Ambulatory
7.5.1. Global Ambulatory Revenue and Growth Rate (2017-2027)
8. Intravenous (IV) Solution Market, By Region
8.1. Introduction
8.2. Global Intravenous (IV) Solution Revenue and Market Share by Regions
8.2.1. Global Intravenous (IV) Solution Revenue by Regions (2017-2027)
8.3. North America Intravenous (IV) Solution by Countries
8.3.1. North America Intravenous (IV) Solution Revenue and Growth Rate (2017-2027)
8.3.2. North America Intravenous (IV) Solution Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Intravenous (IV) Solution by Countries
8.4.1. Europe Intravenous (IV) Solution Revenue and Growth Rate (2017-2027)
8.4.2. Europe Intravenous (IV) Solution Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific Intravenous (IV) Solution by Countries
8.5.1. Asia-Pacific Intravenous (IV) Solution Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Intravenous (IV) Solution Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America Intravenous (IV) Solution by Countries
8.6.1. South America Intravenous (IV) Solution Revenue and Growth Rate (2017-2027)
8.6.2. South America Intravenous (IV) Solution Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa Intravenous (IV) Solution by Countries
8.7.1. Middle East and Africa Intravenous (IV) Solution Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Intravenous (IV) Solution Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Baxter (US)
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Financial Overview
9.2. Amanta Healthcare (India).
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Financial Overview
9.3. Fresenius Kabi AG (Germany)
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Financial Overview
9.4. Terumo Corporation (Japan)
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Financial Overview
9.5. B. Braun Melsungen AG (Germany)
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Financial Overview
9.6. Grifols, SA (Spain)
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Financial Overview
9.7. ICU Medical, Inc. (US)
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Financial Overview
10. Intravenous (IV) Solution Market Forecast (2017-2027)
10.1. Global Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2027)
10.2. Intravenous (IV) Solution Market Forecast by Regions (2017-2027)
10.2.1. North America Intravenous (IV) Solution Market Forecast (2017-2027)
10.2.1.1. United States Intravenous (IV) Solution Market Forecast (2017-2027)
10.2.1.2. Canada Intravenous (IV) Solution Market Forecast (2017-2027)
10.2.1.3. Mexico Intravenous (IV) Solution Market Forecast (2017-2027)
10.2.2. Europe Intravenous (IV) Solution Market Forecast (2017-2027)
10.2.2.1. Germany Intravenous (IV) Solution Market Forecast (2017-2027)
10.2.2.2. France Intravenous (IV) Solution Market Forecast (2017-2027)
10.2.2.3. UK Intravenous (IV) Solution Market Forecast (2017-2027)
10.2.2.4. Russia Intravenous (IV) Solution Market Forecast (2017-2027)
10.2.2.5. Italy Intravenous (IV) Solution Market Forecast (2017-2027)
10.2.2.6. Rest of Europe Intravenous (IV) Solution Market Forecast (2017-2027)
10.2.3. Asia-Pacific Intravenous (IV) Solution Market Forecast (2017-2027)
10.2.3.1. China Intravenous (IV) Solution Market Forecast (2017-2027)
10.2.3.2. Japan Intravenous (IV) Solution Market Forecast (2017-2027)
10.2.3.3. Korea Intravenous (IV) Solution Market Forecast (2017-2027)
10.2.3.4. India Intravenous (IV) Solution Market Forecast (2017-2027)
10.2.3.5. Southeast Asia Intravenous (IV) Solution Market Forecast (2017-2027)
10.2.3.6. Rest of Asia-Pacific Intravenous (IV) Solution Market Forecast (2017-2027)
10.2.4. South America Intravenous (IV) Solution Market Forecast (2017-2027)
10.2.4.1. Brazil Intravenous (IV) Solution Market Forecast (2017-2027)
10.2.4.2. Argentina Intravenous (IV) Solution Market Forecast (2017-2027)
10.2.4.3. Columbia Intravenous (IV) Solution Market Forecast (2017-2027)
10.2.4.4. Rest of South America Intravenous (IV) Solution Market Forecast (2017-2027)
10.2.5. Middle East and Africa Intravenous (IV) Solution Market Forecast (2017-2027)
10.2.5.1. Saudi Arabia Intravenous (IV) Solution Market Forecast (2017-2027)
10.2.5.2. United Arab Emirates Intravenous (IV) Solution Market Forecast (2017-2027)
10.2.5.3. Egypt Intravenous (IV) Solution Market Forecast (2017-2027)
10.2.5.4. Nigeria Intravenous (IV) Solution Market Forecast (2017-2027)
10.2.5.5. South Africa Intravenous (IV) Solution Market Forecast (2017-2027)
10.2.5.6. Turkey Intravenous (IV) Solution Market Forecast (2017-2027)
10.2.5.7. Rest of Middle East and Africa Intravenous (IV) Solution Market Forecast (2017-2027)
10.3. Intravenous (IV) Solution Market Forecast by Types (2017-2027)
10.3.1. Intravenous (IV) Solution Forecast by Types (2017-2027)
10.3.2. Intravenous (IV) Solution Market Share Forecast by Types (2017-2027)
10.4. Intravenous (IV) Solution Market Forecast by Nutritional Content (2017-2027)
10.4.1. Intravenous (IV) Solution Forecast by Nutritional Content (2017-2027)
10.4.2. Intravenous (IV) Solution Market Share Forecast by Nutritional Content (2017-2027)
10.5. Intravenous (IV) Solution Market Forecast by End Users (2017-2027)
10.5.1. Intravenous (IV) Solution Forecast by End Users (2017-2027)
10.5.2. Intravenous (IV) Solution Market Share Forecast by End Users (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Intravenous (IV) Solution Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Intravenous (IV) Solution Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Intravenous (IV) Solution Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Intravenous (IV) Solution Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Intravenous (IV) Solution Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Intravenous (IV) Solution Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Intravenous (IV) Solution Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Intravenous (IV) Solution Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Intravenous (IV) Solution Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Intravenous (IV) Solution Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Intravenous (IV) Solution Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Intravenous (IV) Solution Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Intravenous (IV) Solution Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Intravenous (IV) Solution Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Intravenous (IV) Solution Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Intravenous (IV) Solution Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Intravenous (IV) Solution Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Intravenous (IV) Solution Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Intravenous (IV) Solution Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Intravenous (IV) Solution Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Intravenous (IV) Solution Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Intravenous (IV) Solution Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Intravenous (IV) Solution Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Intravenous (IV) Solution Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Intravenous (IV) Solution Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Intravenous (IV) Solution Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Intravenous (IV) Solution Revenue and Revenue Share by Types (2017-2018)
Figure Global Peripheral Parenteral Nutrition Revenue and Growth Rate (2017-2018)
Figure Global Total Parenteral Nutrition Revenue and Growth Rate (2017-2018)
Table Global Intravenous (IV) Solution Revenue and Revenue Share by Nutritional Content (2017-2018)
Figure Global Carbohydrates Revenue and Growth Rate (2017-2018)
Figure Global Parenteral Lipid Emulsion Revenue and Growth Rate (2017-2018)
Figure Global Carbohydrates Revenue and Growth Rate (2017-2018)
Figure Global Amino Acid Solution Revenue and Growth Rate (2017-2018)
Figure Global Other Revenue and Growth Rate (2017-2018)
Table Global Intravenous (IV) Solution Revenue and Revenue Share by End Users (2017-2018)
Figure Global Hospital & Clinics Revenue and Growth Rate (2017-2018)
Figure Global Home Care Revenue and Growth Rate (2017-2018)
Figure Global Ambulatory Revenue and Growth Rate (2017-2018)
Table Global Intravenous (IV) Solution Revenue by Regions (2017-2018)
Figure North America Intravenous (IV) Solution Growth Rate (2017-2018)
Figure North America Intravenous (IV) Solution Revenue and Growth Rate (2017-2018)
Figure North America Intravenous (IV) Solution by Countries (2017-2018)
Figure North America Intravenous (IV) Solution Revenue (Million USD) by Countries (2017-2018)
Figure United States Intravenous (IV) Solution Growth Rate (2017-2018)
Figure United States Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Intravenous (IV) Solution Growth Rate (2017-2018)
Figure Canada Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Intravenous (IV) Solution Growth Rate (2017-2018)
Figure Mexico Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Intravenous (IV) Solution Growth Rate (2017-2018)
Figure Europe Intravenous (IV) Solution Revenue and Growth Rate (2017-2018)
Figure Europe Intravenous (IV) Solution by Countries (2017-2018)
Figure Europe Intravenous (IV) Solution Revenue (Million USD) by Countries (2017-2018)
Figure Germany Intravenous (IV) Solution Growth Rate (2017-2018)
Figure Germany Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Intravenous (IV) Solution Growth Rate (2017-2018)
Figure France Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Intravenous (IV) Solution Growth Rate (2017-2018)
Figure UK Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Intravenous (IV) Solution Growth Rate (2017-2018)
Figure Russia Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Intravenous (IV) Solution Growth Rate (2017-2018)
Figure Italy Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Intravenous (IV) Solution Growth Rate (2017-2018)
Figure Rest of Europe Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Intravenous (IV) Solution Growth Rate (2017-2018)
Figure Asia-Pacific Intravenous (IV) Solution Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Intravenous (IV) Solution by Countries (2017-2018)
Figure Asia-Pacific Intravenous (IV) Solution Revenue (Million USD) by Countries (2017-2018)
Figure China Intravenous (IV) Solution Growth Rate (2017-2018)
Figure China Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Intravenous (IV) Solution Growth Rate (2017-2018)
Figure Japan Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Intravenous (IV) Solution Growth Rate (2017-2018)
Figure Korea Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Intravenous (IV) Solution Growth Rate (2017-2018)
Figure India Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Intravenous (IV) Solution Growth Rate (2017-2018)
Figure Southeast Asia Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Intravenous (IV) Solution Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Intravenous (IV) Solution Growth Rate (2017-2018)
Figure South America Intravenous (IV) Solution Revenue and Growth Rate (2017-2018)
Figure South America Intravenous (IV) Solution by Countries (2017-2018)
Figure South America Intravenous (IV) Solution Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Intravenous (IV) Solution Growth Rate (2017-2018)
Figure Brazil Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Intravenous (IV) Solution Growth Rate (2017-2018)
Figure Argentina Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Intravenous (IV) Solution Growth Rate (2017-2018)
Figure Columbia Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Intravenous (IV) Solution Growth Rate (2017-2018)
Figure Rest of South America Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Intravenous (IV) Solution Growth Rate (2017-2018)
Figure Middle East and Africa Intravenous (IV) Solution Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Intravenous (IV) Solution by Countries (2017-2018)
Figure Middle East and Africa Intravenous (IV) Solution Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Intravenous (IV) Solution Growth Rate (2017-2018)
Figure Saudi Arabia Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Intravenous (IV) Solution Growth Rate (2017-2018)
Figure United Arab Emirates Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Intravenous (IV) Solution Growth Rate (2017-2018)
Figure Egypt Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Intravenous (IV) Solution Growth Rate (2017-2018)
Figure Nigeria Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Intravenous (IV) Solution Growth Rate (2017-2018)
Figure South Africa Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Intravenous (IV) Solution Growth Rate (2017-2018)
Figure Turkey Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Intravenous (IV) Solution Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2017-2018)
Table Baxter (US) Intravenous (IV) Solution Financial Overview
Table Amanta Healthcare (India). Intravenous (IV) Solution Financial Overview
Table Fresenius Kabi AG (Germany) Intravenous (IV) Solution Financial Overview
Table Terumo Corporation (Japan) Intravenous (IV) Solution Financial Overview
Table B. Braun Melsungen AG (Germany) Intravenous (IV) Solution Financial Overview
Table Grifols, SA (Spain) Intravenous (IV) Solution Financial Overview
Table ICU Medical, Inc. (US) Intravenous (IV) Solution Financial Overview
Figure Global Intravenous (IV) Solution Revenue (Millions USD) and Growth Rate (2018-2025)
Table Intravenous (IV) Solution Market Forecast by Regions (2018-2025)
Figure North America Intravenous (IV) Solution Market Forecast (2018-2025)
Figure United States Intravenous (IV) Solution Market Forecast (2018-2025)
Figure Canada Intravenous (IV) Solution Market Forecast (2018-2025)
Figure Mexico Intravenous (IV) Solution Market Forecast (2018-2025)
Figure Europe Intravenous (IV) Solution Market Forecast (2018-2025)
Figure Germany Intravenous (IV) Solution Market Forecast (2018-2025)
Figure France Intravenous (IV) Solution Market Forecast (2018-2025)
Figure UK Intravenous (IV) Solution Market Forecast (2018-2025)
Figure Russia Intravenous (IV) Solution Market Forecast (2018-2025)
Figure Italy Intravenous (IV) Solution Market Forecast (2018-2025)
Figure Rest of Europe Intravenous (IV) Solution Market Forecast (2018-2025)
Figure Asia-Pacific Intravenous (IV) Solution Market Forecast (2018-2025)
Figure China Intravenous (IV) Solution Market Forecast (2018-2025)
Figure Japan Intravenous (IV) Solution Market Forecast (2018-2025)
Figure Korea Intravenous (IV) Solution Market Forecast (2018-2025)
Figure India Intravenous (IV) Solution Market Forecast (2018-2025)
Figure Southeast Asia Intravenous (IV) Solution Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Intravenous (IV) Solution Market Forecast (2018-2025)
Figure South America Intravenous (IV) Solution Market Forecast (2018-2025)
Figure Brazil Intravenous (IV) Solution Market Forecast (2018-2025)
Figure Argentina Intravenous (IV) Solution Market Forecast (2018-2025)
Figure Columbia Intravenous (IV) Solution Market Forecast (2018-2025)
Figure Rest of South America Intravenous (IV) Solution Market Forecast (2018-2025)
Figure Middle East and Africa Intravenous (IV) Solution Market Forecast (2018-2025)
Figure Saudi Arabia Intravenous (IV) Solution Market Forecast (2018-2025)
Figure United Arab Emirates Intravenous (IV) Solution Market Forecast (2018-2025)
Figure Egypt Intravenous (IV) Solution Market Forecast (2018-2025)
Figure Nigeria Intravenous (IV) Solution Market Forecast (2018-2025)
Figure South Africa Intravenous (IV) Solution Market Forecast (2018-2025)
Figure Turkey Intravenous (IV) Solution Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Intravenous (IV) Solution Market Forecast (2018-2025)
Figure Global Intravenous (IV) Solution Forecast by Types (2018-2025)
Figure Global Intravenous (IV) Solution Market Share Forecast by Types (2018-2025)
Figure Global Intravenous (IV) Solution Forecast by Types (2018-2025)
Figure Global Intravenous (IV) Solution Forecast by Nutritional Content (2018-2025)
Figure Global Intravenous (IV) Solution Market Share Forecast by Nutritional Content (2018-2025)
Figure Global Intravenous (IV) Solution Forecast by Nutritional Content (2018-2025)
Figure Global Intravenous (IV) Solution Forecast by End Users (2018-2025)
Figure Global Intravenous (IV) Solution Market Share Forecast by End Users (2018-2025)
Figure Global Intravenous (IV) Solution Forecast by End Users (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|